New VP of Karmanos Cancer Network
DETROIT–The Barbara Ann Karmanos Cancer Institute has appointed Doris Ranski-Zazula as the vice president of the Karmanos Cancer Network, part of McLaren Health Care. The Karmanos Cancer Network is one of the …
New Karmanos software to ID, manage patients at high risk of cancer
DETROIT–Officials at the Barbara Ann Karmanos Cancer Institute announced the adoption of Volpara Risk Pathways, software designed to simplify risk assessment and patient management for various cancers, including breast, lung, …
Karmanos gets $352k grant for pancreatic cancer research
DETROIT—The Barbara Ann Karmanos Cancer Institute recently received a $352,437 grant from the U CAN-CER VIVE Foundation to help fund a pancreatic cancer research study. The outcomes of this study will help …
Delphinus wins FDA approval for breast ultrasound exam system
NOVI—Officials at Delphinus Medical Technologies Inc. announced that the U.S. Food and Drug Administration has granted premarket approval of its SoftVue 3D Whole Breast Ultrasound Tomography System. The system is …
KSP Specialty Pharmacy expands offerings, adds new website, patient portal
DETROIT—The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) launched new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and …
National Cancer Institute renews core grant for Karmanos
DETROIT—Officials at the Barbara Ann Karmanos Cancer Institute announced that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious NCI designation through 2025, making …
New coronavirus drug therapy under study at Karmanos
DETROIT—An oral therapy that has been studied in laboratory experiments and clinical trials at the Barbara Ann Karmanos Cancer Institute, in partnership with Karyopharm Therapeutics Inc., will soon enter clinical …